Yuji Mizokami

2.2k total citations
82 papers, 1.4k citations indexed

About

Yuji Mizokami is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuji Mizokami has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Surgery, 23 papers in Gastroenterology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuji Mizokami's work include Helicobacter pylori-related gastroenterology studies (21 papers), Inflammatory mediators and NSAID effects (14 papers) and Gastrointestinal disorders and treatments (13 papers). Yuji Mizokami is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (21 papers), Inflammatory mediators and NSAID effects (14 papers) and Gastrointestinal disorders and treatments (13 papers). Yuji Mizokami collaborates with scholars based in Japan, United States and France. Yuji Mizokami's co-authors include Takeshi Matsuoka, Kentaro Sugano, Kiyoshi Ashida, Takashi Kawai, Akira Nishimura, Nobuo Funao, Kazunori Oda, Toshiaki Narasaka, Junichi Iwamoto and Hideo Suzuki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Yuji Mizokami

74 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuji Mizokami Japan 21 651 436 292 289 208 82 1.4k
Hirotoshi Okazaki Japan 21 808 1.2× 508 1.2× 278 1.0× 195 0.7× 183 0.9× 62 1.4k
Yasuhisa Sakata Japan 26 758 1.2× 563 1.3× 487 1.7× 242 0.8× 150 0.7× 98 1.9k
Mitsuyuki Murano Japan 18 554 0.9× 243 0.6× 307 1.1× 313 1.1× 178 0.9× 59 1.6k
Ryuichi Nagashima Japan 18 511 0.8× 250 0.6× 247 0.8× 258 0.9× 82 0.4× 50 1.1k
Hiromu Kutsumi Japan 28 1.1k 1.7× 459 1.1× 834 2.9× 501 1.7× 268 1.3× 119 2.5k
Jakob Hendel Denmark 24 626 1.0× 244 0.6× 150 0.5× 208 0.7× 305 1.5× 85 1.8k
Mariana Jinga Romania 19 386 0.6× 235 0.5× 126 0.4× 288 1.0× 262 1.3× 114 1.2k
Bin Lü China 22 481 0.7× 224 0.5× 277 0.9× 606 2.1× 115 0.6× 79 1.6k
Carlos Augusto Real Martinez Brazil 22 612 0.9× 176 0.4× 196 0.7× 335 1.2× 304 1.5× 160 1.6k
Wan‐Sik Lee South Korea 28 967 1.5× 447 1.0× 908 3.1× 451 1.6× 179 0.9× 137 2.2k

Countries citing papers authored by Yuji Mizokami

Since Specialization
Citations

This map shows the geographic impact of Yuji Mizokami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Mizokami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Mizokami more than expected).

Fields of papers citing papers by Yuji Mizokami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Mizokami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Mizokami. The network helps show where Yuji Mizokami may publish in the future.

Co-authorship network of co-authors of Yuji Mizokami

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Mizokami. A scholar is included among the top collaborators of Yuji Mizokami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Mizokami. Yuji Mizokami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishibashi, Fumiaki, Yoshitaka Tokai, Toshiaki Hirasawa, et al.. (2024). A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms. Gastric Cancer. 27(5). 1078–1087. 3 indexed citations
2.
Kim, Taeho, Sechang Oh, Takashi Shida, et al.. (2021). Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis. International Journal of Environmental Research and Public Health. 18(17). 8918–8918. 8 indexed citations
3.
Okada, Kosuke, Eiji Warabi, Fumihiko Uchida, et al.. (2021). Prevention of non‐alcoholic steatohepatitis by long‐term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. Physiological Reports. 9(9). e14859–e14859. 8 indexed citations
4.
Uchida, Fumihiko, Sechang Oh, Takashi Shida, et al.. (2021). Effects of Exercise on the Oral Microbiota and Saliva of Patients with Non-Alcoholic Fatty Liver Disease. Terrestrial Environment Research Center (University of Tsukuba). 17 indexed citations
5.
Hasegawa, Naoyuki, Kensaku Mori, Masato Endo, et al.. (2021). Percutaneous transhepatic obliteration-related procedures for isolated gastric varices: experience of three cases. Clinical Journal of Gastroenterology. 15(1). 192–198.
6.
Mizokami, Yuji, Takatsugu Yamamoto, Hirotsugu Atarashi, et al.. (2020). Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry. PLoS ONE. 15(11). e0240859–e0240859. 5 indexed citations
7.
Hasegawa, Naoyuki, Yuji Yamaguchi, Masato Endo, et al.. (2020). A case of pancreatic-pleural fistula of Type 1 autoimmune pancreatitis successfully treated with pancreatic drainage and steroid. Clinical Journal of Gastroenterology. 13(5). 946–950. 1 indexed citations
8.
Suzuki, Hideo, Kosuke Okada, Takeshi Yamada, et al.. (2020). Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis. PLoS ONE. 15(10). e0240040–e0240040. 2 indexed citations
9.
Uchiyama, Kan, Hideo Suzuki, Satoshi Mochizuki, et al.. (2020). Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial. PLoS ONE. 15(11). e0241337–e0241337. 25 indexed citations
10.
Suzuki, Hideo, Yuji Mizokami, Masahiko Gosho, et al.. (2018). Long-Term Maintenance Effect of Qing Dai for Ulcerative Colitis. The Journal of Alternative and Complementary Medicine. 24(11). 1130–1131. 7 indexed citations
11.
Ito, Hiromu, et al.. (2018). The preventive effect of Qing Dai on bisphosphonate-induced gastric cellular injuries. Journal of Clinical Biochemistry and Nutrition. 64(1). 45–51. 1 indexed citations
12.
Shida, Takashi, Kentaro Akiyama, Sechang Oh, et al.. (2017). Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. Journal of Gastroenterology. 53(4). 535–547. 68 indexed citations
13.
Oh, Sechang, Eiji Warabi, Kentaro Akiyama, et al.. (2017). Nuclear factor (erythroid derived 2)-like 2 activation increases exercise endurance capacity via redox modulation in skeletal muscles. Scientific Reports. 7(1). 12902–12902. 59 indexed citations
14.
Satoh, Kiichi, Junji Yoshino, Taiji Akamatsu, et al.. (2016). Evidence-based clinical practice guidelines for peptic ulcer disease 2015. Journal of Gastroenterology. 51(3). 177–194. 104 indexed citations
15.
Yokoyama, Kenji, Naoki Ishizuka, Naomi Uemura, et al.. (2015). Effects of Daily Aspirin on Cancer Incidence and Mortality in the Japanese. Blood. 126(23). 2322–2322. 1 indexed citations
16.
Hirayama, Takeshi, Yuji Mizokami, Akira Honda, et al.. (2009). Serum concentration of 27‐hydroxycholesterol predicts the effects of high‐cholesterol diet on plasma LDL cholesterol level. Hepatology Research. 39(2). 149–156. 29 indexed citations
17.
Iwamoto, Junichi, Yuji Mizokami, Kimiko Takahashi, Takeshi Matsuoka, & Yasushi Matsuzaki. (2008). The Effects of Cyclooxygenase2–ProstaglandinE2 Pathway onHelicobacter pylori‐Induced Urokinase‐Type Plasminogen Activator System in the Gastric Cancer Cells. Helicobacter. 13(3). 174–182. 27 indexed citations
18.
Honda, Akira, et al.. (2007). Highly sensitive assay of HMG-CoA reductase activity by LC-ESI-MS/MS. Journal of Lipid Research. 48(5). 1212–1220. 15 indexed citations
19.
Iwamoto, Junichi, et al.. (2003). Expression of Urokinase-Type Plasminogen Activator and Its Receptor in Gastric Fibroblasts and Effects of Nonsteroidal Antiinflammatory Drugs and Prostaglandin. Digestive Diseases and Sciences. 48(12). 2247–2256. 15 indexed citations
20.
Mizokami, Yuji, et al.. (1986). UPPER GASTROINTESTINAL ENDOSCOPIC FINDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS. Acta gastro-enterologica belgica. 28(10). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026